Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 96,235,272
  • Shares Outstanding, K 474,767
  • Annual Sales, $ 6,675 M
  • Annual Income, $ 1,638 M
  • 60-Month Beta 0.65
  • Price/Sales 14.52
  • Price/Cash Flow 42.46
  • Price/Book 23.59
Trade ZTS with:

Options Overview

Details
  • Implied Volatility 23.57%
  • Historical Volatility 14.33%
  • IV Percentile 29%
  • IV Rank 28.85%
  • IV High 38.38% on 10/28/20
  • IV Low 17.56% on 06/14/21
  • Put/Call Vol Ratio 0.32
  • Today's Volume 322
  • Volume Avg (30-Day) 1,143
  • Put/Call OI Ratio 0.99
  • Today's Open Interest 29,585
  • Open Int (30-Day) 31,418

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 1.08
  • Number of Estimates 6
  • High Estimate 1.17
  • Low Estimate 1.02
  • Prior Year 0.89
  • Growth Rate Est. (year over year) +21.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
186.61 +8.62%
on 07/01/21
205.67 -1.44%
on 07/29/21
+16.34 (+8.77%)
since 06/30/21
3-Month
165.22 +22.68%
on 05/06/21
205.67 -1.44%
on 07/29/21
+29.67 (+17.15%)
since 04/30/21
52-Week
141.41 +43.34%
on 03/05/21
205.67 -1.44%
on 07/29/21
+53.59 (+35.94%)
since 07/30/20

Most Recent Stories

More News
3 Red-Hot Stocks Still Worth Buying

Even though the major benchmark indexes are hovering near all-time highs thanks to impressive corporate earnings and forecasts, many analysts expect the stock market to suffer a correction on concerns...

MCD : 242.71 (-0.54%)
ZTS : 202.70 (-0.70%)
RSG : 118.36 (+2.49%)
Eli Lilly (LLY) to Report Q2 Earnings: What's in the Cards?

Higher demand for its growth drugs is likely to have offset generic competition for several other drugs and may have boosted Lilly's (LLY) second-quarter sales.

REGN : 574.61 (-1.46%)
LLY : 243.50 (-0.75%)
MRNA : 353.60 (+2.30%)
ZTS : 202.70 (-0.70%)
Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ZTS : 202.70 (-0.70%)
CORT or ZTS: Which Is the Better Value Stock Right Now?

CORT vs. ZTS: Which Stock Is the Better Value Option?

CORT : 20.77 (+2.37%)
ZTS : 202.70 (-0.70%)
Zoetis vs. Chewy: Which Pet Stock is a Better Buy?

Rising spending on pet food and care products with increased pet adoption amid the COVID-19 pandemic is driving the pet industry’s growth. So, we believe Zoetis (ZTS) and Chewy (CHWY) are likely to benefit...

ZTS : 202.70 (-0.70%)
CHWY : 83.70 (-3.43%)
Why Zoetis (ZTS) Could Beat Earnings Estimates Again

Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ZTS : 202.70 (-0.70%)
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?

Style Box ETF report for FTCS

FTCS : 78.00 (+0.01%)
UPS : 191.36 (-0.23%)
EW : 112.27 (+0.58%)
SPY : 438.51 (-0.49%)
ZTS : 202.70 (-0.70%)
IVV : 440.40 (-0.51%)
Alexion (ALXN) Reports Positive Data on Ultomiris From gMG Study

Alexion (ALXN) announces that the phase III study of Ultomiris for the indication of gMG met its primary goal.

AZN : 57.24 (-0.69%)
ALXN : 182.50 (+1.70%)
RGEN : 245.70 (+1.95%)
ZTS : 202.70 (-0.70%)
AcelRx (ACRX) Inks Agreement With Aguettant for Dzuveo in Europe

AcelRx (ACRX) enters a licensing agreement for Dzuveo in Europe and an in-licensing agreement for two products in the United States.

RGEN : 245.70 (+1.95%)
ACRX : 1.1800 (-1.67%)
ZTS : 202.70 (-0.70%)
ACAD : 21.63 (-2.96%)
TFF Pharmaceuticals (TFFP) Completes Enrollment in Phase I Study

TFF Pharmaceuticals (TFFP) completes enrollment in the phase I study on tacrolimus inhalation powder and announces positive preliminary data.

BAYRY : 14.8550 (-1.82%)
HALO : 41.33 (+0.63%)
ZTS : 202.70 (-0.70%)
TFFP : 8.29 (-5.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.

See More

Key Turning Points

3rd Resistance Point 205.83
2nd Resistance Point 205.01
1st Resistance Point 203.86
Last Price 202.70
1st Support Level 201.89
2nd Support Level 201.07
3rd Support Level 199.92

See More

52-Week High 205.67
Last Price 202.70
Fibonacci 61.8% 181.12
Fibonacci 50% 173.54
Fibonacci 38.2% 165.96
52-Week Low 141.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar